Nurix Therapeutics, Inc. - stock earnings
NRIX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -24.3 million USD | 30.7 million USD |
| 2022Q4 | -46.7 million USD | 6.8 million USD |
| 2022Q3 | -45.7 million USD | 10.8 million USD |
| 2022Q2 | -45.4 million USD | 11.4 million USD |
| 2022Q1 | -42.5 million USD | 9.6 million USD |
| 2021Q4 | -37.7 million USD | 7.4 million USD |
| 2021Q3 | -28.8 million USD | 10.3 million USD |
| 2021Q2 | -26.4 million USD | 7.1 million USD |
| 2021Q1 | -24.3 million USD | 5.0 million USD |
| 2020Q4 | -19.9 million USD | 6.7 million USD |
| 2020Q3 | -18.5 million USD | 4.1 million USD |
| 2020Q2 | 7.6 million USD | 4.2 million USD |
NRIX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -143.9 million USD | 77.0 million USD |
| 2022 | -166.0 million USD | 38.6 million USD |
| 2021 | -117.2 million USD | 29.8 million USD |
| 2020 | -43.2 million USD | 17.8 million USD |
| 2019 | -21.7 million USD | 31.1 million USD |
| 2018 | -9.4 million USD | 37.4 million USD |
NRIX
Price: $12.78
52 week price:
Earnings Per Share: -2.65 USD
P/E Ratio: -2.97
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 161700
Market Capitalization: 720.1 million